Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19

Convalescent plasma has emerged as a promising therapeutic agent for patients with coronavirus disease 2019 (COVID-19), has received emergency use authorization, and is being widely used during the COVID-19 pandemic. Passive antibody therapy via plasma or serum has been successfully used to treat in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Microbiol Newsl
Hlavní autoři: Ripoll, Juan G., van Helmond, Noud, Senefeld, Jonathon W., Wiggins, Chad C., Klassen, Stephen A., Baker, Sarah E., Larson, Kathryn F., Murphy, Brenna M., Andersen, Kylie J., Ford, Shane K., Casadevall, Arturo, Joyner, Michael J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7862032/
https://ncbi.nlm.nih.gov/pubmed/33564204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clinmicnews.2021.02.001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky